GereStodderDizeregaMD

Obstetrics & Gynecology • Los Angeles, CA

Reproductive Endocrinology & Infertility

Physician

Join to view full profile

Are you Dr. Dizerega?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 37 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
1321 N Mission Rd
Los Angeles, CA 90033
Phone+1 323-226-4965

Summary

Dr. Gere Dizerega, MD is an obstetrician/gynecologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is affiliated with Los Angeles General Medical Center.

Education & Training

University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Obstetrics and Gynecology, 1974 - 1978
Baylor College of MedicineClass of 1974

Certifications & Licensure

CA State Medical License 1975 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility

Clinical Trials

Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy Start of enrollment: 2008 Sep 01
Terminated
Phase 1
Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer Start of enrollment: 2008 Oct 01
Completed
Phase 2
Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers Start of enrollment: 2008 Oct 01
Completed
Phase 2
Safety and Efficacy of TXA127 and Neupogen to Increase Peripheral Blood Stem Cells (PBSCs) Start of enrollment: 2009 Dec 01
Completed
Phase 1
Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test Start of enrollment: 2016 Aug 01
Completed
Phase 1
Phase II Study of Intraperitoneal NanoPac® in Patients With Ovarian Cancer Start of enrollment: 2017 Apr 19
Terminated
Phase 2
Expanded Access to NanoPac
Available
Expanded Access to NanoDoce
Available
Join now to see all

Publications & Presentations

PubMed

Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with...
Gere S diZerega, Holly A Maulhardt, Shelagh J Verco, Alyson M Marin, Michael J Baltezor
Oncology and Therapy. 2024-03-01
2 citations
Intratumoral Treatment of Melanoma Tumors with Large Surface Area Microparticle Paclitaxel and Synergy with Immune Checkpoint Inhibition.
Holly A Maulhardt, Alyson M Marin, Gere S diZerega
International Journal of Nanomedicine. 2024-01-01
8 citations
Local administration of large surface area microparticle docetaxel to solid carcinomas induces direct cytotoxicity and immune-mediated tumoricidal effects: preclinical...
Holly Maulhardt, Shelagh Verco, Michael Baltezor, Alyson Marin, Gere diZerega
Drug Delivery and Translational Research. 2023-02-01